| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogen Receptor alpha | 11 | 2023 | 478 | 1.640 |
Why?
|
| Breast Neoplasms | 14 | 2025 | 2762 | 1.420 |
Why?
|
| Nuclear Receptor Coactivator 3 | 7 | 2020 | 351 | 0.770 |
Why?
|
| Endocrine Disruptors | 3 | 2020 | 54 | 0.590 |
Why?
|
| Breast | 2 | 2018 | 218 | 0.550 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2024 | 829 | 0.540 |
Why?
|
| Transcription, Genetic | 8 | 2020 | 1757 | 0.520 |
Why?
|
| E1A-Associated p300 Protein | 4 | 2020 | 58 | 0.520 |
Why?
|
| Proteomics | 3 | 2018 | 605 | 0.500 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2021 | 2125 | 0.480 |
Why?
|
| MCF-7 Cells | 9 | 2020 | 233 | 0.470 |
Why?
|
| RNA, Long Noncoding | 2 | 2016 | 248 | 0.460 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2025 | 50 | 0.450 |
Why?
|
| Estrogens | 6 | 2024 | 524 | 0.450 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2025 | 67 | 0.450 |
Why?
|
| Response Elements | 2 | 2015 | 108 | 0.430 |
Why?
|
| Transcriptional Activation | 5 | 2018 | 500 | 0.420 |
Why?
|
| Nucleosomes | 1 | 2013 | 40 | 0.410 |
Why?
|
| DNA | 3 | 2020 | 1676 | 0.400 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 396 | 0.390 |
Why?
|
| Neurofibromin 1 | 2 | 2025 | 50 | 0.390 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 2145 | 0.380 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 429 | 0.370 |
Why?
|
| HeLa Cells | 8 | 2017 | 839 | 0.350 |
Why?
|
| RNA, Untranslated | 1 | 2010 | 120 | 0.310 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2021 | 271 | 0.290 |
Why?
|
| Receptors, Estrogen | 4 | 2025 | 829 | 0.290 |
Why?
|
| Cell Line, Tumor | 8 | 2025 | 3794 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 624 | 0.280 |
Why?
|
| Neoplasm Proteins | 3 | 2024 | 713 | 0.270 |
Why?
|
| Endometriosis | 2 | 2024 | 186 | 0.270 |
Why?
|
| Signal Transduction | 6 | 2020 | 4917 | 0.270 |
Why?
|
| Receptors, Androgen | 2 | 2020 | 433 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 5 | 2018 | 1420 | 0.250 |
Why?
|
| Trans-Activators | 2 | 2013 | 835 | 0.240 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 1341 | 0.230 |
Why?
|
| Genes, ras | 1 | 2004 | 101 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2025 | 1013 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 211 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2025 | 612 | 0.210 |
Why?
|
| Protein Binding | 5 | 2020 | 1852 | 0.210 |
Why?
|
| Transcription Factors | 4 | 2017 | 2720 | 0.210 |
Why?
|
| Estrogen Antagonists | 2 | 2020 | 107 | 0.200 |
Why?
|
| Receptors, Steroid | 1 | 2024 | 276 | 0.190 |
Why?
|
| Glucose | 2 | 2018 | 917 | 0.190 |
Why?
|
| Tamoxifen | 2 | 2020 | 377 | 0.190 |
Why?
|
| Humans | 31 | 2025 | 133373 | 0.190 |
Why?
|
| Animals | 17 | 2025 | 36222 | 0.180 |
Why?
|
| Unfolded Protein Response | 1 | 2020 | 65 | 0.170 |
Why?
|
| Apoptosis | 3 | 2024 | 1928 | 0.170 |
Why?
|
| Organotin Compounds | 1 | 2020 | 6 | 0.160 |
Why?
|
| Phosphorylation | 4 | 2018 | 1707 | 0.160 |
Why?
|
| Stilbenes | 1 | 2020 | 42 | 0.160 |
Why?
|
| Trialkyltin Compounds | 1 | 2019 | 7 | 0.160 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2019 | 19 | 0.160 |
Why?
|
| Hormones | 1 | 2020 | 197 | 0.160 |
Why?
|
| Models, Biological | 3 | 2020 | 1531 | 0.160 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 236 | 0.160 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 1693 | 0.150 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2016 | 250 | 0.150 |
Why?
|
| Histones | 3 | 2017 | 572 | 0.150 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 80 | 0.150 |
Why?
|
| Multiprotein Complexes | 3 | 2017 | 219 | 0.150 |
Why?
|
| Cell Proliferation | 3 | 2025 | 2559 | 0.150 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 24 | 0.140 |
Why?
|
| Hepatocytes | 1 | 2019 | 245 | 0.140 |
Why?
|
| Transcription Initiation, Genetic | 1 | 2017 | 8 | 0.140 |
Why?
|
| Guanylate Cyclase | 1 | 2017 | 38 | 0.140 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 767 | 0.140 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2017 | 14 | 0.140 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2017 | 44 | 0.140 |
Why?
|
| RNA Polymerase II | 1 | 2017 | 102 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 384 | 0.140 |
Why?
|
| Histone Code | 1 | 2017 | 53 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2019 | 714 | 0.130 |
Why?
|
| Mutation | 5 | 2023 | 6343 | 0.130 |
Why?
|
| Female | 16 | 2025 | 71503 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 124 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 386 | 0.130 |
Why?
|
| Lysine | 1 | 2017 | 207 | 0.130 |
Why?
|
| Mice | 10 | 2025 | 18936 | 0.120 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 363 | 0.120 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 12 | 0.120 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2015 | 17 | 0.120 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2016 | 75 | 0.120 |
Why?
|
| Methyltransferases | 1 | 2016 | 83 | 0.120 |
Why?
|
| Luciferases | 3 | 2013 | 136 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 176 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 1325 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2019 | 1240 | 0.110 |
Why?
|
| Chromatin | 1 | 2018 | 617 | 0.110 |
Why?
|
| HEK293 Cells | 4 | 2020 | 824 | 0.110 |
Why?
|
| Binding Sites | 4 | 2018 | 1378 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 1849 | 0.100 |
Why?
|
| Sialoglycoproteins | 1 | 2013 | 46 | 0.100 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2013 | 21 | 0.100 |
Why?
|
| Pyridines | 2 | 2025 | 250 | 0.100 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 71 | 0.100 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2013 | 13 | 0.100 |
Why?
|
| Models, Molecular | 3 | 2020 | 1147 | 0.100 |
Why?
|
| Recombinant Proteins | 3 | 2020 | 1433 | 0.100 |
Why?
|
| Peptide Fragments | 2 | 2017 | 828 | 0.100 |
Why?
|
| Piperazines | 2 | 2025 | 256 | 0.100 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 99 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 2651 | 0.100 |
Why?
|
| Ribonuclease III | 1 | 2013 | 103 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2012 | 9 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 721 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2016 | 1136 | 0.100 |
Why?
|
| Cryoelectron Microscopy | 3 | 2020 | 246 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 150 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2004 | 59 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2017 | 150 | 0.090 |
Why?
|
| Homeostasis | 1 | 2015 | 748 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 390 | 0.090 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2010 | 7 | 0.080 |
Why?
|
| Iodide Peroxidase | 1 | 2010 | 9 | 0.080 |
Why?
|
| RNA Interference | 3 | 2018 | 546 | 0.080 |
Why?
|
| Transfection | 3 | 2017 | 1095 | 0.080 |
Why?
|
| Histone Acetyltransferases | 2 | 2015 | 319 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 117 | 0.080 |
Why?
|
| Liver | 1 | 2017 | 1860 | 0.080 |
Why?
|
| Mice, Nude | 2 | 2021 | 780 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 787 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 622 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 335 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 1097 | 0.070 |
Why?
|
| Estradiol | 2 | 2020 | 560 | 0.070 |
Why?
|
| Cell Survival | 2 | 2020 | 884 | 0.070 |
Why?
|
| Endometrium | 2 | 2024 | 290 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2013 | 1072 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 607 | 0.070 |
Why?
|
| Acetylation | 2 | 2017 | 196 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1606 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 1067 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 745 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1558 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2020 | 689 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2020 | 873 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2013 | 945 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2025 | 119 | 0.060 |
Why?
|
| Obesity | 1 | 2017 | 2440 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2020 | 614 | 0.060 |
Why?
|
| Silver Staining | 1 | 2004 | 5 | 0.060 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2004 | 8 | 0.060 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2004 | 9 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2004 | 71 | 0.060 |
Why?
|
| Baculoviridae | 1 | 2004 | 68 | 0.060 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2004 | 49 | 0.060 |
Why?
|
| CREB-Binding Protein | 1 | 2004 | 66 | 0.060 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2004 | 52 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2004 | 93 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2017 | 805 | 0.050 |
Why?
|
| Transcriptome | 2 | 2021 | 1135 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2004 | 391 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2024 | 234 | 0.050 |
Why?
|
| Cell Line | 2 | 2019 | 2853 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 211 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1915 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 10954 | 0.050 |
Why?
|
| Rats | 2 | 2020 | 3851 | 0.050 |
Why?
|
| Progesterone | 1 | 2024 | 636 | 0.040 |
Why?
|
| Benzothiazoles | 1 | 2020 | 31 | 0.040 |
Why?
|
| Dihydrotestosterone | 1 | 2020 | 73 | 0.040 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2020 | 31 | 0.040 |
Why?
|
| Neoplasms | 1 | 2016 | 2992 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 103 | 0.040 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 79 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2020 | 146 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 702 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 2785 | 0.040 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2020 | 39 | 0.040 |
Why?
|
| Prognosis | 2 | 2021 | 5044 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2020 | 36 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2020 | 86 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 39 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2020 | 202 | 0.040 |
Why?
|
| Deoxyglucose | 1 | 2019 | 42 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2024 | 899 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 302 | 0.040 |
Why?
|
| Knowledge Bases | 1 | 2019 | 40 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 98 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 212 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 260 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 4760 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2020 | 130 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 318 | 0.040 |
Why?
|
| ras Proteins | 1 | 2020 | 146 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 571 | 0.040 |
Why?
|
| Epigenomics | 1 | 2020 | 196 | 0.040 |
Why?
|
| Adiposity | 1 | 2020 | 207 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 42 | 0.040 |
Why?
|
| Transketolase | 1 | 2018 | 19 | 0.040 |
Why?
|
| Mammals | 1 | 2019 | 282 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4823 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 35 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 44 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2019 | 781 | 0.040 |
Why?
|
| Purines | 1 | 2018 | 119 | 0.030 |
Why?
|
| TATA Box | 1 | 1997 | 25 | 0.030 |
Why?
|
| TATA-Box Binding Protein | 1 | 1997 | 31 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 173 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 232 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 171 | 0.030 |
Why?
|
| Survival Rate | 1 | 2021 | 2207 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 323 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 415 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1714 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2015 | 63 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1997 | 541 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 348 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2016 | 236 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 1583 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 2013 | 28 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2013 | 69 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1140 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1303 | 0.020 |
Why?
|
| Base Sequence | 1 | 1997 | 3153 | 0.020 |
Why?
|
| Drosophila | 1 | 2017 | 828 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1838 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1731 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1997 | 3960 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 67 | 0.020 |
Why?
|
| Plasmids | 1 | 2013 | 529 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 911 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 771 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 399 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1997 | 2877 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 323 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 676 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1411 | 0.020 |
Why?
|
| Cell Movement | 1 | 2012 | 906 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 3979 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 6544 | 0.020 |
Why?
|
| Male | 2 | 2020 | 65592 | 0.010 |
Why?
|